Extracorporeal Therapies in Non-Renal Disease: Treatment of Sepsis and the Peak Concentration Hypothesis
- 20 January 2004
- journal article
- review article
- Published by S. Karger AG in Blood Purification
- Vol. 22 (1), 164-174
- https://doi.org/10.1159/000074937
Abstract
In the setting of intensive care, patients with acute renal failure often present a clinical picture of the systemic inflammatory response syndrome (SIRS). SIRS can be caused by bacterial stimuli or by non-microbiological stimuli that induce a significant inflammatory response. When this response is exaggerated, the patient experiences multiple organ system failure and a condition of sepsis also defined as a systemic malignant inflammation. This is mostly characterized by an invasion of cytokines and other pro-inflammatory mediators into the systemic circulation where major biological effects take place, including vasopermeabilization, hypotension and shock. At the same time, the monocyte of the septic patient seems to be hyporesponsive to inflammatory stimuli to a certain extent. In this condition, the patient faces a situation of hyperinflammation but at the same time of immunodepression expressing a clinical entity defined as counter anti-inflammatory response syndrome. The general picture of the clinical disorder is therefore better characterized by an immunodysregulation than by a simple pro- or anti-inflammatory disorder. Due to the short half-life of cytokines and other mediators spilled over into the circulation, it is extremely difficult to approach the problem at the right moment with the right pharmacological agent. For these reasons, the peak concentration hypothesis suggests that continuous renal replacement therapies, due to their continuity and unspecific capacity of removal, might be beneficial in cutting the peaks of the concentrations of both pro- and anti-inflammatory mediators, restoring a situation of immunohomeostasis. Thus the patient may benefit from a lesser degree of immunodysregulation and he/she may restore a close-to-normal capacity of response to exogenous stimuli.Keywords
This publication has 31 references indexed in Scilit:
- Dysfunction of Endothelial Protein C Activation in Severe Meningococcal SepsisNew England Journal of Medicine, 2001
- Modulation of soluble phases of endothelial/leukocyte adhesion molecule 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 with interleukin-1β after experimental endotoxic challengeCritical Care Medicine, 2001
- The protein C pathwayCritical Care Medicine, 2000
- Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-α attenuation during endotoxic shockCritical Care Medicine, 1999
- Vascular-Bed–Specific Hemostasis and Hypercoagulable StatesNew England Journal of Medicine, 1999
- Diffusive vs. convective therapyCritical Care Medicine, 1998
- Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta.The Journal of Experimental Medicine, 1995
- Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltrationCritical Care Medicine, 1995
- Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.The Journal of Experimental Medicine, 1991
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986